palbociclib
Showing 26 - 50 of 184
Lung Cancer Squamous Cell, Solid Tumors, Head & Neck Cancer Trial in Boston (Palbociclib, Gedatolisib)
Recruiting
- Lung Cancer Squamous Cell
- +3 more
- Palbociclib
- Gedatolisib
-
Boston, Massachusetts
- +2 more
Jan 9, 2023
Breast Cancer, Breast Carcinoma, Cancer of Breast Trial in Saint Louis, Lincoln (Palbociclib, Letrozole, Fulvestrant)
Active, not recruiting
- Breast Cancer
- +3 more
- Palbociclib
- +7 more
-
Saint Louis, Missouri
- +1 more
Jul 20, 2022
Malignant Solid Tumor, Ovarian Low Grade Serous Adenocarcinoma, Pancreatic Carcinoma Trial (Binimetinib, Biopsy, Biospecimen
Not yet recruiting
- Malignant Solid Neoplasm
- +4 more
- Binimetinib
- +6 more
- (no location specified)
Nov 8, 2022
Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (drug, radiation, procedure)
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- Palbociclib
- +5 more
-
Saint Louis, MissouriWashington University School of Medicine
Feb 25, 2022
Breast Tumor Female Trial in Melbourne (Venetoclax, Palbociclib, Letrozole)
Recruiting
- Breast Neoplasm Female
- Venetoclax
- +2 more
-
Melbourne, Victoria, Australia
- +2 more
Mar 10, 2022
Malignant Female Reproductive System Tumor, Malignant Solid Tumor, Recurrent Malignant Female Reproductive System Tumor Trial
Not yet recruiting
- Malignant Female Reproductive System Neoplasm
- +3 more
- Biopsy
- +7 more
- (no location specified)
Nov 9, 2023
Patterns and Clinical Outcomes of Palbociclib Treated Israel
Completed
- Metastatic Breast Cancer
- palbociclib
-
Herzliya Pituach, IsraelPfizer Pharmaceuticals Israel Ltd.
Jan 20, 2022
Colorectal Carcinoma, Lung Adenocarcinoma, Malignant Solid Tumor Trial in Buffalo (Binimetinib, Palbociclib, Therapeutic
Recruiting
- Colorectal Carcinoma
- +3 more
- Binimetinib
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
May 11, 2022
Advanced Breast Cancer Trial in China (Palbociclib, Letrozole)
Active, not recruiting
- Advanced Breast Cancer
- Palbociclib
- Letrozole
-
Beijing, Beijing, China
- +6 more
Jun 23, 2022
Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)
Recruiting
- Triple Negative Breast Cancer
- +5 more
- Palbociclib
- Avelumab
-
Manchester, Greater Manchester, United Kingdom
- +6 more
Jan 5, 2023
Head and Neck Squamous Cell Carcinoma Trial in La Jolla (Avelumab, Palbociclib, Cetuximab)
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- Avelumab
- +2 more
-
La Jolla, CaliforniaUC San Diego Moores Cancer Center
Feb 16, 2022
Ewing Sarcoma, Ewing's Sarcoma Recurrent Trial in Boston (Palbociclib, Ganitumab)
Active, not recruiting
- Ewing Sarcoma
- Ewing's Sarcoma Recurrent
- Palbociclib
- Ganitumab
-
Boston, Massachusetts
- +2 more
Mar 21, 2022
HER2-positive Breast Cancer, Breast Cancer, Breast Cancer Stage Trial in United States (Palbociclib, T-DM1)
Completed
- HER2-positive Breast Cancer
- +5 more
- Palbociclib
- T-DM1
-
Tucson, Arizona
- +15 more
Dec 22, 2022
Metastatic Breast Cancer Trial in United States (Palbociclib, Fulvestrant)
Recruiting
- Metastatic Breast Cancer
- Palbociclib
- Fulvestrant
-
Washington, District of Columbia
- +4 more
Jan 10, 2022
Metastatic Breast Cancer, Unresectable Breast Cancer Trial in United States (Letrozole, Palbociclib, Onapristone ER)
Recruiting
- Metastatic Breast Cancer
- Unresectable Breast Cancer
- Letrozole
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Sep 12, 2022
Cancer of the Colon, Colon Cancer, Colon Tumors Trial in Chapel Hill (Cetuximab, Palbociclib)
Recruiting
- Cancer of the Colon
- +4 more
- Cetuximab
- Palbociclib
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Jan 25, 2022
Metastatic Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7 Trial in United States (drug, other, biological)
Suspended
- Metastatic Breast Carcinoma
- Stage IV Breast Cancer AJCC v6 and v7
- Fulvestrant
- +4 more
-
Corona, California
- +6 more
Sep 28, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Anastrozole,
Active, not recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +6 more
- Anastrozole
- +6 more
-
Atlanta, Georgia
- +9 more
Oct 12, 2022
KRAS Mutant NSCLC, Solid Tumors Trial in Boston (Palbociclib, PD-0325901)
Active, not recruiting
- KRAS Mutant Non-Small Cell Lung Cancer
- Solid Tumors
- Palbociclib
- PD-0325901
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 18, 2022
HPV-unrelated Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (Palbociclib, Cetuximab)
Recruiting
- HPV-unrelated Head and Neck Squamous Cell Carcinoma
- Palbociclib
- Cetuximab
-
Saint Louis, MissouriWashington University School of Medicine
Apr 7, 2022
Breast Cancer Trial in Australia (OP-1250, Palbociclib)
Recruiting
- Breast Cancer
- OP-1250
- Palbociclib
-
Westmead, New South Wales, Australia
- +4 more
Feb 23, 2022